Events

Keynote on U.S. Health Reform at Global E-Health Forum - Hamburg 2010

25-26 October 2010, Hamburg, Germany.
Harry Reynolds, Chair of the National Committee on Vital and Health Statistics (NCVHS) and Chair of Council for Affordable Quality Healthcare (CAQH) CORE Initiative, will deliver the keynote speech at the Global E-Health Forum. Title of his presentation is "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The PHARM Connect Congress 2011

9-10 February 2011, Budapest, Hungary.
The PHARM Connect Congress 2011, an event organised by The Events Group, offers the perfect setting for solution providers to present their products and services directly to key decision makers of target client population throughout Central & Eastern Europe. Strictly operating on an invitation only basis guarantees that the highest level of delegation is present. Each solution provider at the PHARM Connect Congress is selected based on requirements and interests provided by attending Pharmaceutical professionals prior to the Congress event.

Innovation in Healthcare: From Research to Market. SMEs in Focus

20-21 May 2010, Brussels, Belgium.
The Research DG and Enterprise & Industry DG are jointly organizing the Conference Innovation in Healthcare. From Research to Market. SMEs in Focus, in Brussels on 20-21 May 2010. Different stakeholders involved in the innovation process of bringing drugs, therapies and medical technologies into market will participate.

Global E-Health Forum - Hamburg 2010

25-26 October 2010, Hamburg, Germany.
The Global E-Health Forum has been conceived to create a unique opportunity to discuss potential solutions in patient-centric health management. The past three Baltic Conferences on E-Health (2007-2009) have generated considerable interest in countries far beyond the Baltic Sea Region. The reason is simple: Healthcare systems all over the world are facing very similar challenges.

Clinical Trials in Oncology

16-17 September 2010, Budapest, Hungary.
Cancer is the fastest growing healthcare priority within the pharmaceutical industry worldwide, with rising research, treatment and commercial importance. Carefully designed and efficiently conducted clinical trial can deliver new oncology drugs and diagnostics to the marketplace. There is a number of challenges in this area which remain; specifically regarding patient recruitment and regulatory issues.

Preliminary final report: Strong analytica reinforces leading position

analytica 2010 has closed its gates in Munich with nearly 33,000 visitors from 120 countries. An audience of highly qualified visitors and an increase in the number of exhibitors to 1,038 companies from 37 countries created an atmosphere of optimism in the industry. Visitors gave the fair top marks: They confirmed analytica as the industry's leading trade fair and praised it for the presence of all key players.

6th Annual Achieving Quality & Process Excellence in the Pharmaceutical Industry

15 - 17 September 2010, Lisbon, Portugal.
What are the best practices to achieve QC Laboratory Excellence? How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems? Leading Pharmaceutical companies will share their first hand experience with transforming the mindset of people, creating the culture of change and continuous improvement in both Quality and Operational Excellence.

Events

More Pharma News ...